Last Updated: September, 2020
This Privacy Notice (“Notice”) is provided by PharmaEssentia USA, (“Us,” “We,” “Our”) to explain what personal information we collect about you (“You,” “User”), how we collect it, for what purposes, and to whom we may disclose the information. Additionally, this Notice informs you about how you may limit uses of your personal information and exercise your rights, where applicable, relating to personal information that we collect, maintain and disclose about you.
This Notice applies to PharmaEssentia USA websites, social media pages (collectively, “Sites”) and surveys, patient and healthcare professional support activities, and other activities (collectively, “Services”) that reference or display this Notice.
PharmaEssentia USA respects your privacy and we encourage you to read this entire Notice carefully before using or submitting information to us through our Sites or Services. Your continued access and use of PharmaEssentia USA Sites and Services means you acknowledge that you understand and agree to the terms of this Notice. If you have any questions regarding PharmaEssentia USA’s privacy practices or wish to exercise your rights relating to personal information PharmaEssentia USA has collected or maintains about you, please contact us as described in the “CONTACT US” section, below.
Personal Information We Collect & Use
PharmaEssentia USA collects various categories of personal information about you, including information you provide directly through our Sites, through your participation in our programs, or to receive our Services.
This information may include, for example:
- Contact Information. We collect this information to communicate with you, and may include your name, mailing address, telephone number, email address, age, and other information you provide through our Site or Services. It is your choice as to whether to provide your personal information.
- Professional Information. This information helps us manage our relationships with individuals with whom we interact, and may include job title, educational information, professional qualifications, work experience, professional networks, programs and activities.
- Interests & Preferences. This information helps us understand your interest in our products and Services so that we can best serve you. This information may include contact and product preferences, languages, marketing preferences and demographic data. In some cases, we may be required to collect this information based on your consent. In other cases, where allowed under applicable law, we collect this information automatically, for our legitimate business interests.
- Health, Biometric & Genetic Information. This information may relate to identifiable individuals, or non-identifiable individuals and is only collected as permitted and in compliance with applicable laws for permissible purposes such as providing employee benefits, in the course of providing products and Services, and for regulatory reporting, where required.
- Transaction History & Account Information. This information helps us fulfil Services you have requested and to understand your interests and preferences. This includes information about how you interact with us and use our Sites and Services, correspondence history, and customer account information. When we have provided a Service to you, we use this information in order to perform the Service or fulfill an agreement with you. In other cases, where allowed under applicable law, we collect this information automatically, for our legitimate business interests.
- Digital & Security Information. We use this information to secure our websites, network systems, and other assets. This may include information concerning your IP Address, geographic location, resources you have accessed, and similar information. We collect this information automatically, for our legitimate business interests.
- Further Information We May Collect. Where permitted by law, we may also combine personal information collected through our Sites and Services with PharmaEssentia USA’s offline records and information obtained from public or third-party sources. We use this consolidated information to improve our Sites and Services, enhance our marketing activities, better design our offerings, and facilitate other business functions.
Where we are required by law to ask for your consent before collecting personal information, we will present you with a choice as to whether you wish to allow the collection and use of this type of information.
Retention of Personal Information
PharmaEssentia will retain personal information we collect about you for the amount of time necessary to fulfill the purposes as described in this Notice, and as otherwise permitted under applicable law.
Cookies & Analytic Services
Cookies. Our Sites may use a tracking technology called a “cookie.” A cookie is a small data file that a website can place on your computer’s hard drive, where your internet browser files are kept. Cookies help us to make your experience and interactions with our Sites more efficient and easier for you by remembering things like your language, display and other setting preferences. Cookies may be placed on your computer both by us and by third parties with whom we have a relationship, such as web analytic services and advertising network services. These cookies can help us to share content from our social media sites, gain helpful insights about how our Sites are used and how we can improve your experiences and interactions with our Sites.
Your browser settings can be changed to manage and reject cookies, based on your preferences. However, if you choose to modify settings limiting or rejecting cookies, you may not be able to interact with our Sites to the same extent, and the Site’s functionality may be lost or diminished. For more information about cookies and how to manage, block and delete them, please visit: http://www.allaboutcookies.org.
How We Share Personal Information
PharmaEssentia USA does not sell or rent your personal information.
We may disclose your personal information to certain third parties for various business purposes, including, without limitation, third parties who provide us with services such as monitoring and maintaining our Sites and Services, fulfillment and customer service-related services, marketing, communication, and other services. We require these third-party service providers to treat your personal information in a manner consistent with this Privacy Notice, and to implement appropriate security measures to maintain the confidentiality, integrity and availability of the personal information we share with them.
We may also share your personal information with PharmaEssentia USA affiliates within our group of companies, in compliance with applicable laws, and to comply with regulatory requirements and financial transparency laws. We may also disclose your personal information to third parties in special cases, including when necessary to identify, contact, or bring legal action against a party who may be causing injury to or interfering with our rights, property or safety or those of any other person, and as required under applicable law.
In the event of a business transaction, such as an acquisition, merger, sale, divestment or other change in control of PharmaEssentia USA, information we have about you may be transferred to a third party as part of that transaction. The acquiring entity will be required to use the personal information that is transferred only in a manner that is consistent with this Notice.
Online Protection of Children
Our Sites are not intended for children. We do not knowingly collect personal information from children under 13-years old. However, if the parent or the guardian of a child under 13 years old believes that the child has provided us with personal information, the parent or guardian of that child should contact us at firstname.lastname@example.org to request the information’s deletion. Anyone under 13 years old should seek their parent’s or guardian’s permission prior to using our Site or disclosing any personal information to PharmaEssentia USA.
Security of Personal Information
PharmaEssentia USA takes commercially reasonable steps to protect your personal information from unauthorized access, use and disclosure. While we use technical, physical and administrative controls to safeguard personal information, we cannot guarantee the security of the Internet, transmissions or email sent using this Site or other online resources.
Your Rights Related to Your Personal Information
PharmaEssentia USA respects your choices about the collection and use of your personal information, and, where required under applicable law, we respect your rights to request information regarding personal information about you that collect, maintain, use, and disclose. We will, in good faith, take reasonable steps to respond and comply with your requests to exercise your applicable rights. When we are unable or prohibited to honor your request, we will inform you of our decision within the required timeframe.
To evaluate a request by you to access or delete your information, we may ask you to provide additional information to confirm your identity. We will not discriminate against you for exercising your rights, but we may not be able to provide you with Services or programs that you have requested if we are not able to use your information. To submit requests please contact us as described in the “CONTACT US” section, below.
Changes to this Privacy Notice
PharmaEssentia USA reserves the right to amend this Notice at our discretion. When changes are made, we will post the updated Notice and the date of its revision. Revisions to this Notice will not be applied retroactively.
If you have any questions regarding PharmaEssentia USA’s privacy practices or wish to exercise your rights relating to your personal information, please contact us at:
35 Corporate Drive, Suite 325
Burlington, MA 01803, USA
Contact us online
Lih-Ling Lin, Ph.D.
Chief Scientific Officer
Lih-Ling Lin, PhD, joined PharmaEssentia in August 2022 to lead the company’s global research and development (R&D) activities to expand and diversify the pipeline and to enhance the company’s R&D engagement globally and in critical markets.
Prior to PharmaEssentia, Lih-Ling was a leader at Sanofi in Boston where she was the Head of Checkpoint immunology cluster in Immunology and Inflammation Research Area, following a long tenure at Pfizer in senior research and development roles. Her work in both companies led to the discovery of clinical candidates, including small molecules and antibodies for immune-mediated diseases.
Lih-Ling graduated from National Taiwan University with an undergraduate degree in Pharmacy and a master’s degree in biochemistry. She earned her doctorate in biochemistry at the University of Arizona. She has published more than 70 papers and patents on immunology-related topics.
VP, Head of Corporate Communications and Advocacy
Rachel Lipsitz joined PharmaEssentia USA in September 2022, bringing two decades of experience in developing and implementing strategic communications and advocacy relations programs for life sciences and biopharmaceutical companies.
She joined PEC USA from Bristol-Myers Squibb where she led all external science and R&D communications activities and was the communications lead for the company in California.
Rachel received a bachelor of science degree from The University of Texas at Austin where she majored in public relations with a focus in business foundations.
Raymond Urbanski, MD, PhD
SVP, Head of Clinical Development and Medical Affairs
Ray Urbanski joined PharmaEssentia in 2020 as SVP and Head of Clinical Development and Medical Affairs for the U.S. organization. An established clinical researcher, licensed clinician and pharmaceutical executive, Ray has more than 25 years of experience in research, clinical practice, and the pharmaceutical industry. Prior to PharmaEssentia, Dr. Urbanski served as Chief Medical Officer (CMO) and President of GT Biopharma, Inc. He was previously the CMO of MannKind Corporation, as well as at Mylan. Earlier, Dr. Urbanski spent almost a decade at Pfizer holding several positions, including CMO of the Established Products Business Unit and Senior Medical Director of the Oncology Clinical R&D group. Prior to industry, he spent three years in a private practice.
Ray received his MD and PhD in Pharmacology from the New Jersey Medical School, and completed his Residency and Fellowship training at Thomas Jefferson University Hospital in Philadelphia.
Sulin Shah joined PharmaEssentia in 2021 as U.S. General Counsel. Prior to joining PharmaEssentia, Mr. Shah served as U.S. General Counsel at Orphazyme where he supported extensive U.S. organizational and infrastructure development. Prior to Orphazyme, Sulin was Lead Counsel in U.S. Hematology for Takeda, following the acquisition of Shire. Earlier in his career, he served in private legal practice and management consulting roles in Chicago.
Shah earned his BS in business administration from the University of Illinois and his JD from Northwestern University.
SVP, Head of People
Anjana joined PharmaEssentia in 2022 as SVP and Head of People. Anjana is a business and organizational development leader with over 25 years of experience across pharmaceutical, consumer and financial industries. Most recently, Anjana ran a global Executive Coaching and Organizational Effectiveness firm, where she partnered with senior leaders and organizations to create sustainable growth and change. Prior to this, Anjana held a 20-year tenure as a high-performance marketing professional in the pharmaceutical and consumer packaged goods industries.
Anjana holds an MBA from Dartmouth and a BA in Economics from Rutgers University.
VP, Head of Market Access
Jason Mitch joined PharmaEssentia in March 2021, introducing more than 20 years of experience in biopharmaceutical companies focusing primarily on patient and market access. Prior to his tenure at PharmaEssentia, he supported access and reimbursement for Fergene, and previously developed his expertise through roles of increasing leadership during his tenure at Actelion.
Jason received an MFT from Hahnemann University and a BS from The Ohio State University.
SVP, Head of Sales and Marketing
Roddy joined PharmaEssentia in 2021 as Head of Sales and Marketing. Prior to PharmaEssentia, he served as Vice President of Oncology-Hematology Sales at Jazz Pharmaceuticals. During his tenure, he successfully led launches for four products in the leukemia, transplant and lung cancer markets. He cultivated his earlier career in sales and marketing roles at Otsuka America Pharmaceuticals, Genentech and Ortho Biotech (now Johnson & Johnson).
Roddy received his BS in marketing from the University of South Carolina and an Executive MBA from Webster University.
President, The Americas
Meredith Manning joined PharmaEssentia USA Corporation in 2020 and currently serves as President of the Americas. She has more than 25 years of experience in global commercialization and brand building for biopharmaceuticals and medical devices. Meredith has played an instrumental role in defining and leading PharmaEssentia’s strategic growth and ambition across the Americas, including building a robust leadership team, bringing the organization’s first asset to market and growing the company into a recognized global biopharmaceutical innovator.
Prior to joining PharmaEssentia, Meredith was Chief Commercial Officer at resTORbio™, and previously served as Vice President of Global Product Strategy in Hemophilia for Shire (formerly Baxalta) and Baxter. She has also held a series of marketing leadership roles at Vertex® and Pfizer.
Meredith received a BS at Colorado College and an IMBA from the University of Chicago Booth School of Business.
Jack Hwang, Ph.D.
General Manager, Taiwan
Jack Hwang joined PharmaEssentia in 2006 and has served as General Manager in Taiwan since 2015. With training in organic chemistry, he has held a series of leadership roles at prior companies, including as Senior Director at Optimer Pharmaceuticals, Senior Group Leader at Array BioPharma®, and earlier as a research scientist at Amgen® and Ligand® Pharmaceuticals.
Jack completed his Ph.D. in organic chemistry and post-doctoral fellowship in natural product synthesis at the University of Pennsylvania.
Albert Qin, M.D. Ph.D.
Chief Medical Officer
Albert Qin, who joined PharmaEssentia in 2017, brings more than 20 years of experience in the biotech and pharmaceutical industry with an emphasis on clinical development. Recent leadership roles include Chief Medical Officer at China Health Group, Chief Scientific Officer and Corporate Officer at SymBio Pharmaceuticals, and Medical Director at ImmunoGen™. Earlier in his career, he held clinical development and R&D roles at Pfizer, Bayer and Biogen®. At Biogen, he did innovative research and made discoveries related to cytokines, immunology, and gene therapy.
Albert completed his medical degree in the Department of Medicine at Shandong Medical University in China and his Ph.D. in biochemistry and molecular pharmacology at Harvard Medical School. He completed a visiting research fellowship at Brigham and Women’s Hospital.
Ching-Leou Teng, Ph.D.
Chairperson of the Board of Directors
Ching-Leou Teng offers extensive pharmaceutical science and development expertise to the PharmaEssentia team. After joining the company as head of operations in 2003, she became Chairperson in 2009. Prior to PharmaEssentia, Ching-Leou held multiple leadership roles in drug delivery research and pharmaceutical development at Ionis™ (formerly ISIS) Pharmaceuticals, and previously served as a reviewer in the Pharmacokinetics Evaluation Branch of the Division of Biopharmaceutics at the Food and Drug Administration (FDA). Early in her career, Ching-Leou was a registered pharmacist at hospitals in Taiwan.
Ching-Leou completed her B.S. in pharmacy at Taipei Medical College, followed by an M.S. in pharmaceutical science at North Dakota State University. She completed her Ph.D. and post-doctoral fellowship at the University of Michigan.
Ko-Chung Lin, Ph.D.
Founder and Chief Executive Officer
Ko-Chung Lin has led PharmaEssentia since 2002, driven by rich and diverse career experiences at leading U.S. pharmaceutical companies. He is recognized for medicinal chemistry advances in pegylation, including the invention of pegylated-interferon, that have led to the development and successful entry of multiple leading therapeutics. Prior to PharmaEssentia, Ko-Chung was head of the Adentri® and pegylated-Avonex® programs at Biogen®. Earlier in his career, he contributed to inventions in HIV in his research roles at Monsanto.
Ko-Chung received B.S. and M.S. degrees in chemistry from National Taiwan Normal University, his Ph.D. from the University of Missouri, and completed a post-doctoral fellowship at the University of Michigan.